The program, called YesRx, takes in donations and dispenses oral cancer and supportive medications to those in need, giving ...

Annovis Bio, Inc. (NYSE: ANVS) ('Annovis” or the 'Company”), a late-stage clinical drug platform company pioneering ...

Shoppers Drug Mart billed the Ontario government’s MedsCheck program $81.2 million for medication reviews over a two-year ...

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

"My father had disappeared five or six years before, after a custody battle and then a failure to pay child support." ...

The FDA’s new Commissioner’s National Priority Voucher signals a transformative shift in U.S. drug review, tying accelerated approval to manufacturing readiness, domestic supply-chain strength, and ...

THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / ...

Company dispensed over 1,000 FDA-cleared systems in pilot phase; unveils new website and second-generation device for early 2026 launch ...

Teaming up with the Healey & AMG Center, Inflammasome will advance its oral ALS drug kamuvudine-9, known as K9, into early clinical testing.

Almost every seat was filled in the Delta County 47th Circuit Courtroom to celebrate the 16th Delta County Drug/Sobriety ...

Operated by the federal government, TrumpRx aims to reduce the amount that Americans — including Medicaid patients — pay for ...